South Africa drug giant Adcock Ingram in pact for Indian ops sale
BY PTI10 April 2016 9:27 PM GMT
PTI10 April 2016 9:27 PM GMT
South Africa’s second biggest drug marker Adcock Ingram has confirmed it has found a buyer for its Indian marketing and sales operations but will retain the manufacturing and regulatory capacity of Cosme Farma. The MNC spent eight months trying to sell off the Indian company it had acquired in 2013 for R745 million (Rs 328 crore) in the hope of taking advantage of the growth in the Indian medicines market. But for the past two years, Adcock Ingram has made losses of more than R50 million annually amid a struggle to make inroads in the highly competitive Indian market. The company announced that it would dispose of its 100 per cent shareholding in Adcock Ingram Healthcare Private Limited, its marketing and selling operation in India, to private equity firm Samara Capital Partners for R336 million. “The Indian pharmaceutical marketing and selling business does not meet the company’s current investment criteria and as a result the company has decided to exit this business,” Adcock Ingram said in a statement.
Next Story
In 100 bail orders: 'Videos' used for arrest in 44; 32 of these failed...
22 Feb 2021 7:11 PM GMTDelhi Police say 1,753 held but courts heard over 4,347 bail pleas
21 Feb 2021 8:26 PM GMT755 FIRs and 342 chargesheets against 1,553 people later – not a...
21 Feb 2021 7:48 PM GMTOf courts' bugbears, most common 'doubtful' police, public witness...
23 Feb 2021 7:29 PM GMTA Delhi Police-sized roadblock in victims' path to justice — clubbing...
25 Feb 2021 7:39 PM GMT
CWG: Shuttlers, paddlers dazzle on last day
8 Aug 2022 8:15 PM GMTMumbai court remands Sanjay Raut to 14-day judicial custody
8 Aug 2022 7:45 PM GMTCWG: Fast-rising boxer Sagar Ahlawat wins silver on international...
8 Aug 2022 7:45 PM GMTCWG: India settle for silver in men's hockey, lose 0-7 to Australia in...
8 Aug 2022 7:44 PM GMTVirat Kohli, KL Rahul back in India squad for Asia Cup
8 Aug 2022 7:44 PM GMT